Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:2233 (Glytoucan)

Id:f087caa5-a24e-5a86-a239-5241f17dfcae

Glytoucan:G68758PE

Results found

Linked to

	Label	Description
	GLYCOSYLATION.SITE:SITE00032220 CUI has saccharide label:2233 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000086 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2233 has glycosequence GLYGEN.GLYCOSEQUENCE:G20170YB-GLYCOSEQ00031717 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2233 has glycosequence GLYGEN.GLYCOSEQUENCE:G65365UP-GLYCOSEQ00000314 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00034477 CUI has saccharide label:2233 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00032173 CUI has saccharide label:2233 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000064 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2233 has canonical residue n-glycan b-d-glcpnac 11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000010 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00032220 CUI has saccharide label:2233

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000086 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2233 has glycosequence GLYGEN.GLYCOSEQUENCE:G20170YB-GLYCOSEQ00031717 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2233 has glycosequence GLYGEN.GLYCOSEQUENCE:G65365UP-GLYCOSEQ00000314 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00034477 CUI has saccharide label:2233

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00032173 CUI has saccharide label:2233

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000064 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2233 has canonical residue n-glycan b-d-glcpnac 11

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2233 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000010 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.